← The Wire
AXSMNasdaq
Axsome Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1579428
Develops novel therapies for central nervous system disorders with limited treatment options
red 8-K · 90d
$13.13B
Market cap
$241.12
Last close
-0.2%
1D
-2.7%
5D
1.4M
Volume
Price · last 39 sessions+7.8%
May 4L $216.47 · H $255.17Jun 29
319
Total filings
Jun 9, 2026
Last filing
12/31
Fiscal year end
8-KExecutive ChangeJun 9, 20268-KShareholder VoteJun 9, 20268-KCompany UpdateJun 3, 202610-Q10-QMay 4, 20268-KResults of Operations · Company UpdateMay 4, 20268-KCompany UpdateApr 30, 2026DEFA14ADEFA14AApr 24, 2026DEF 14ADEF 14AApr 24, 20268-KCompany UpdateApr 1, 202610-K10-KFeb 23, 20268-KResults of OperationsFeb 23, 20268-KCompany UpdateFeb 17, 20268-KResults of Operations · Company UpdateJan 12, 20268-KCompany UpdateDec 31, 202510-Q10-QNov 3, 20258-KResults of Operations · Company UpdateNov 3, 20258-KCompany UpdateAug 20, 202510-Q10-QAug 4, 20258-KResults of Operations · Company UpdateAug 4, 20258-KCompany UpdateJun 10, 20258-KShareholder VoteJun 9, 20258-KCompany UpdateJun 9, 20258-KCompany UpdateMay 27, 20258-KMaterial Agreement · Agreement TerminatedMay 13, 202510-Q10-QMay 5, 20258-KResults of Operations · Company UpdateMay 5, 2025DEFA14ADEFA14AApr 25, 2025DEF 14ADEF 14AApr 25, 20258-KCompany UpdateApr 1, 20258-KCompany UpdateMar 25, 20258-KCompany UpdateMar 5, 20258-KCompany UpdateMar 3, 202510-K10-KFeb 18, 20258-KResults of Operations · Company UpdateFeb 18, 20258-KCompany UpdateFeb 10, 20258-KCompany UpdateJan 31, 20258-KResults of Operations · Company UpdateJan 13, 20258-KCompany UpdateDec 30, 20248-KCompany UpdateNov 26, 202410-Q10-QNov 12, 20248-KResults of Operations · Company UpdateNov 12, 20248-KMaterial AgreementOct 1, 20248-KCompany UpdateSep 4, 20248-KCompany UpdateAug 21, 202410-Q10-QAug 5, 20248-KResults of OperationsAug 5, 20248-KShareholder VoteJun 11, 20248-KCompany UpdateJun 5, 202410-Q10-QMay 6, 20248-KResults of OperationsMay 6, 2024DEF 14ADEF 14AApr 26, 20248-KCompany UpdateApr 1, 20248-KCompany UpdateMar 25, 20248-KCompany UpdateMar 25, 20248-KCompany UpdateMar 19, 202410-K10-KFeb 23, 20248-KCompany UpdateFeb 20, 20248-KResults of OperationsFeb 20, 20248-KCompany UpdateJan 8, 20248-KResults of Operations · Company UpdateJan 4, 20248-KCompany UpdateDec 7, 202310-Q10-QNov 6, 20238-KResults of OperationsNov 6, 20238-KExecutive Change · Reg FD DisclosureOct 11, 20238-KCompany UpdateAug 15, 202310-Q10-QAug 7, 20238-KResults of OperationsAug 7, 20238-KCompany UpdateAug 4, 2023SC 13GSC 13GJul 7, 20238-KCompany UpdateJul 7, 20238-KCompany UpdateJun 30, 2023424B5424B5Jun 29, 20238-KCompany UpdateJun 29, 2023424B5424B5Jun 28, 20238-KAuditor ChangeJun 26, 20238-KCompany UpdateJun 13, 20238-KExecutive Change · Shareholder VoteJun 8, 202310-Q10-QMay 9, 20238-KResults of OperationsMay 8, 2023DEF 14ADEF 14AApr 21, 2023
Insider Activity
In the 90 days to Feb 26, 2026: 6 sold $61.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 26, 2026 | Jacobson Mark L.Chief Operating Officer | Sell | 35,378 | $161.88 | $5.7M |
| Feb 26, 2026 | Coleman MarkDirector | Sell | 25,000 | $161.11 | $4.0M |
| Feb 2, 2026 | Tabuteau HerriotChief Executive Officer | Sell | 32,410 | $185.60 | $6.0M |
| Jan 22, 2026 | Pizzie NickChief Financial Officer | Sell | 12,000 | $187.92 | $2.3M |
| Jan 21, 2026 | Maizel AriChief Commercial Officer | Sell | 7,500 | $184.44 | $1.4M |
| Jan 7, 2026 | Tabuteau HerriotChief Executive Officer | Sell | 31,261 | $170.38 | $5.3M |
| Jan 6, 2026 | Tabuteau HerriotChief Executive Officer | Sell | 29,450 | $172.33 | $5.1M |
| Jan 5, 2026 | Tabuteau HerriotChief Executive Officer | Sell | 78,703 | $171.28 | $13.5M |
| Dec 31, 2025 | Saad Mark EDirector | Sell | 31,346 | $165.18 | $5.2M |
| Dec 31, 2025 | Saad Mark EDirector | Sell | 6,231 | $165.18 | $1.0M |
| Dec 4, 2025 | Tabuteau HerriotChief Executive Officer | Sell | 10,558 | $148.18 | $1.6M |
| Dec 3, 2025 | Tabuteau HerriotChief Executive Officer | Sell | 20,163 | $146.94 | $3.0M |
| Dec 2, 2025 | Tabuteau HerriotChief Executive Officer | Sell | 49,252 | $144.59 | $7.1M |
| Nov 5, 2025 | Tabuteau HerriotChief Executive Officer | Sell | 21,775 | $134.49 | $2.9M |
| Nov 4, 2025 | Tabuteau HerriotChief Executive Officer | Sell | 50,459 | $133.79 | $6.8M |
| Nov 3, 2025 | Tabuteau HerriotChief Executive Officer | Sell | 91,705 | $132.34 | $12.1M |
| Oct 8, 2025 | Tabuteau HerriotChief Executive Officer | Sell | 12,774 | $118.84 | $1.5M |
| Oct 7, 2025 | Tabuteau HerriotChief Executive Officer | Sell | 13,390 | $118.77 | $1.6M |
| Oct 6, 2025 | Tabuteau HerriotChief Executive Officer | Sell | 19,220 | $120.17 | $2.3M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance